SFDA approves registration of Pemazyre for cholangiocarcinoma ...Saudi Arabia

ٍٍٍSaudi Gazette - News
SFDA approves registration of Pemazyre for cholangiocarcinoma
Saudi Gazette reportRIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of Pemazyre (Pemigatinib) as a monotherapy for adults with locally advanced or metastatic cholangiocarcinoma.

Hence then, the article about sfda approves registration of pemazyre for cholangiocarcinoma was published today ( ) and is available on ٍٍٍSaudi Gazette ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SFDA approves registration of Pemazyre for cholangiocarcinoma )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News